The main protease (3CLp) of the SARS-CoV-2, the causative agent for the COVID-19 pandemic,isone of the main targets for drug development. To be active,3 CLp relies on ac omplex interplay between dimerization, active site flexibility,a nd allosteric regulation. The deciphering of these mechanisms is ac rucial step to enable the search for inhibitors.I n this context, using NMR spectroscopy, we studied the conformation of dimeric 3CLp from the SARS-CoV-2 and monitored ligand binding,based on NMR signal assignments. We performed af ragment-based screening that led to the identification of 38 fragment hits.T heir binding sites showed three hotspots on 3CLp,t wo in the substrate binding pocket and one at the dimer interface. F01 is anon-covalent inhibitor of the 3CLp and has antiviral activity in SARS-CoV-2 infected cells.T his study sheds light on the complex structure-function relationships of 3CLp and constitutes astrong basis to assist in developing potent 3CLp inhibitors.